Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454960 · ClinicalTrials.gov registry record · NA
Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)
A NA study of Acute Respiratory Infections (ARIs), sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01454960 is a NA study of Acute Respiratory Infections (ARIs) that has completed, run by University of Southern California. The registered enrollment target is 28 participants, below the 354-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01454960, a NA study of Acute Respiratory Infections (ARIs), has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the development of resistant strains. Though providers are adequately trained to know when antibiotics are and are not comparatively effective, this has not been sufficient to affect critical provider practices. The intent of this study is to apply behavioral economic theory to reduce the rate of antibiotic prescriptions for acute respiratory diagnoses for which guidelines do not call for antibiotics. Specifically targeted are infections that are likely to be viral. The objective of this study is to improve provider decisions around treatment of acute respiratory infections. The participants are practicing attending physicians or advanced practice nurses (i.e. providers) at participating clinics who see acute respiratory infection patients. A maximum of 550 participants will be recruited for this study. Providers consenting to participate will fill out a baseline questionnaire online. Subsequent to baseline data collection and enrollment, participating clinic sites will be randomized to the study arms, as described below. There will be a control arm, with clinic sites randomized in a multifactorial design to up to three interventions that leverage the electronic medical record: Order Sets that are triggered by EHR workflow containing exclusively guideline concordant choices (SA, for Suggested Alternatives); Accountable Justification (AJ) triggered by discordant prescriptions that populate the note with provider's rationale for guideline exceptions ; and performance feedback that benchmarks providers' own performance to that of their peers (PC, for Peer Comparison). The outcomes of interest are antibiotic prescribing patterns, including prescribing rates and changes in prescr
Conditions Studied
Interventions
- BEHAVIORAL Audit and Feedback: Peer Comparison
- BEHAVIORAL CDS Order Sets: Suggested Alternatives
- BEHAVIORAL Clinical Decision Support: Accountable Justification
Study Locations (1)
Illinois
- Northwestern Medical Faculty Foundation General Internal Medicine Clinic - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01454960
The ClinicalTrials.gov registry entry for NCT01454960 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 354-participant average among 3 other Acute Respiratory Infections (ARIs) trials with a reported enrollment target (92% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Respiratory Infections (ARIs) appearing as the primary indexed condition, and to 3 interventions - of which Audit and Feedback: Peer Comparison is the first listed.
NCT01454960 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01454960 about?
NCT01454960 is a clinical study titled "Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Pilot Study)". Bacteria resistant to antibiotic therapy are a major public health problem. The evolution of multi-drug resistant pathogens may be encouraged by provider prescribing behavior. Inappropriate use of antibiotics for nonbacterial infections and overuse of broad spectrum antibiotics can lead to the devel...
What is the current status of trial NCT01454960?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2011-07. Estimated completion is 2014-09.
What conditions does trial NCT01454960 study?
This clinical trial studies the following conditions: Acute Respiratory Infections (ARIs).
What interventions are being tested in trial NCT01454960?
The interventions under investigation include: Audit and Feedback: Peer Comparison (BEHAVIORAL), CDS Order Sets: Suggested Alternatives (BEHAVIORAL), Clinical Decision Support: Accountable Justification (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454960?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01454960 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Infections (ARIs)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.